Referral source, symptoms, and severity at diagnosis of ocular hypertension or open-angle glaucoma in various practices

Canadian Journal of Ophthalmology

Volumn 47, Issue 3, 2012, Pages 217-222

  Buys, Yvonne M ^a   Gaspo, Rania ^b   Kwok, Kenneth ^b  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; EYE EXAMINATION; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTICENTER STUDY; OPEN ANGLE GLAUCOMA; PATIENT REFERRAL; PHYSICIAN; PROSPECTIVE STUDY;

EID: 84862294736     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1016/j.jcjo.2012.03.031     Document Type: Article

References (41)

1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-7. (Pubitemid 43325451)
2. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull WHO. 2004;82:844-51. 2004. (Pubitemid 39573742)
3. Perruccio AV, Badley EM, Trope GE. Self-reported glaucoma in Canada: Findings from population-based surveys, 1994-2003. Can J Ophthalmol. 2007;42:219-16.
4. Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary open-angle glaucoma among white and black Americans: The Baltimore Eye Survey. Arch Ophthalmol. 1991;109: 1090-5.
5. Coffey M, Reidy A, Wormald R, et al. Prevalence of glaucoma in the west of Ireland. Br J Ophthalmol. 1993;77:17-21. (Pubitemid 23031807)
6. Mitchell P, Smith W, Attebo K, Healey PR. Prevalence of open angle glaucoma in Australia: The Blue Mountains Eye Study. Ophthalmology. 1996;103:1661-9. (Pubitemid 26357144)
7. Rafuse PE, Buys YM, Damji KF, et al. Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of glaucoma in the adult eye. Can J Ophthalmol. 2009;44 Suppl:S7-93.
8. Rudnicka AR, Mt-Isa R, Owen CG, et al. Variations in primary openangle glaucoma prevalence by age, gender, and race: a Bayesian metaanalysis. Invest Ophthalmol Vis Sci. 2006;47:4254-61. (Pubitemid 46579346)
9. Buhrmann R, Hodge W, Beardmore MA. Foundations for a Canadian vision health strategy: towards preventing avoidable blindness and promotion vision health. The National Coalition for Vision Health. January 2007. Available at www.visionhealth.ca/projects/documents/Foundations-For-A-Canadian-Vision-Health- Strategy.pdf. Accessed: March 13, 2011.
10. Damji KF, Behki R, Wang L, Target IOP, workshop participants. Canadian perspectives in glaucoma management: Setting target intraocular pressure range. Can J Ophthalmol. 2003;38:189-97. (Pubitemid 36637480)
11. MacKean JM, Elkington AR. Referral routes to hospital of patients with chronic open-angle glaucoma. BMJ (Clin Res Ed). 1982;285:1093-5. (Pubitemid 12029703)
12. Sheldrick JH, Ng C, Austin DJ, Rosenthal AR. An analysis of referral routes and diagnostic accuracy in cases of suspected glaucoma. Ophthal Epidemiol. 1994;1:31-9.
13. Ng WS, Agarwal PK, Sidiki S, et al. The effect of socio-economic deprivation on severity of glaucoma at presentation. Br J Ophthalmol. 2010; 94:85-7.
14. Hattenhauer MG, Johnson DH, Ing HH, et al. The probability of blindness from open-angle glaucoma. Ophthalmology. 1998;105:2099-104. (Pubitemid 30211780)
15. Grant WM, Burke JF. Why do some people go blind from glaucoma? Ophthalmologe. 1982;89:991-8. (Pubitemid 12001626)
16. Wilson R, Walker AM, Dueker DK, Crick RP Risk factors for rate of progression of glaucomatous visual field loss: A computer-based analysis. Arch Ophthalmol. 1982;100:737-41. (Pubitemid 12156585)
17. Mikelberg FS, Schulzer M, Drance SM, LauWThe rate of progression of scotomas in glaucoma. Am J Ophthalmol. 1986;101:1-6. (Pubitemid 16128717)
18. Odberg T. Visual field prognosis in advanced glaucoma. Acta Ophthalmol. 1987;65:27-9. (Pubitemid 18028373)
19. Parc CE, Johnson DH, Oliver JE, et al. The long-term outcome of glaucoma filtration surgery. Am J Ophthalmol. 2001;132:27-35. (Pubitemid 32600886)
20. Chen PP. Blindness in patients with treated open-angle glaucoma. Ophthalmologe. 2003;110:726-33. (Pubitemid 36520071)
21. Iskedjian M, Walker J, Vicente C, et al. Cost of glaucoma in Canada: analysis based on visual field and physician's assessment. J Glaucoma. 2003;12:456-62. (Pubitemid 37494171)
22. Martinez GC, Campbell AJ, Reinken J, Allan BC. Prevalence of ocular disease in a population study of subjects 65 years old and older. Am J Ophthalmol. 1982;94:181-9. (Pubitemid 12038550)
23. LeskeMC,ConnellAM,WuSY, et al. Risk factors for open angle glaucoma: The Barbados Eye Study. Arch Ophthalmol. 1995;113:918-24.
24. Kaimbo DK, Buntinx F, Missotten L. Risk factors for open-angle glaucoma: A case-control study. J Clin Epidemiol. 2001;54:166-71. (Pubitemid 32112374)
25. Mukesh BN, McCarty CA, Rait JL, Taylor HR. Five-year incidence of open-angle glaucoma: The visual impairment project. Ophthalmology. 2002;109:1047-51. (Pubitemid 34546909)
26. Fraser S, Bunce C, Wormald R. Retrospective analysis of risk factors for late presentation of chronic glaucoma. Br J Ophthalmol. 1999;83:24-8. (Pubitemid 29106325)
27. Fraser S, Bunce C, Wormald R. Risk factors for late presentation in chronic glaucoma. Invest Ophthalmol Vis Sci. 1999:4:2251-7. (Pubitemid 29418379)
28. Quigley HA, Enger C, Katz J, et al. Risk factors for the development of glaucomatous visual field loss in ocular hypertension. Arch Ophthalmol. 1994;112:644-9. (Pubitemid 24155438)
29. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: Baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:714-20. (Pubitemid 34620349)
30. Landers J, Goldberg I, Graham SL. Analysis of risk factors that may be associated with progression from ocular hypertension to primary openangle glaucoma. Clin Exper Ophthalmol. 2002;30:242-7.
31. Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: The Early Manifest Glaucoma Trial. Arch Ophthalmol. 2003;121:48-56. (Pubitemid 36401765)
32. Le A, Mukesh BN, McCarty CA, Taylor HR. Risk factors associated with the incidence of open-angle glaucoma: The visual impairment project. Invest Ophthalmol Vis Sci. 2003;44:3783-9. (Pubitemid 37051537)
33. Thomas R, Parikh R, George R, et al. Five-year risk of progression of ocular hypertension to primary open angle glaucoma: A populationbased study. Indian J Ophthalmol. 2003;51:329-33. (Pubitemid 38082262)
34. Nouri-Mahdavi K, Hoffman D, Coleman AL, et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology. 2004;111:1627-35. (Pubitemid 39179673)
35. Foster PJ, Machin D, Wong TY, et al. Determinants of intraocular pressure and its association with glaucomatous optic neuropathy in Chinese Singaporeans: The Tanjong Pagar Study. Invest Ophthalmol Vis Sci. 2003;44:3885-91. (Pubitemid 37047959)
36. Nemesure B, Wu SY, Hennis A, Leske MC, Barbados Eye Study Group. Corneal thickness and intraocular pressure in the Barbados Eye Studies. Arch Ophthalmol. 2003;121:240-4. (Pubitemid 36184038)
37. Iwase A, Suzuki Y, Araie M, et al.; for the Tajimi Study Group, Japan Glaucoma Society. The prevalence of primary open-angle glaucoma in Japan: The Tajimi Study. Ophthalmology. 2004;111:1641-8. (Pubitemid 39179676)
38. Vijaya L, George R, Paul PG, et al. Prevalence of open-angle glaucoma in a rural south Indian population. Invest Ophthalmol Vis Sci. 2005;46: 4461-7. (Pubitemid 44264539)
39. Pascolini D, Mariotti SP, Pokharel GP, et al. Global update of available data on visual impairment: A compilation of population-based prevalence studies. Ophthal Epidemiol. 2002:67-115. (Pubitemid 38530465)
40. Einarson TR, Vicente C, Machado M, et al. Screening for glaucoma in Canada: A systematic review of the literature. Can J Ophthalmol. 2006; 41:709-21. (Pubitemid 46113024)
41. Burr JM, Mowatt G, Hernández R, et al. The clinical effectiveness and cost-effectiveness of screening for open-angle glaucoma: A systematic review and economic evaluation. Health Technol Assess. 2007; 11:1-190.